AA
ABBV icon

AlphaQ Advisors’s AbbVie ABBV Stock Holding History

AlphaQ Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,879
Closed -$280K – 154
2023
Q3 		$280K Sell
1,879
-303
-14% -$44.5K 0.24% 121
2023
Q2 		$294K Buy
2,182
+887
+68% +$130K 0.22% 135
2023
Q1 		$206K Sell
1,295
-661
-34% -$101K 0.18% 141
2022
Q4 		$316K Buy
+1,956
New +$300K 0.27% 100

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AlphaQ Advisors's ABBV Position: Q4 2023 in Review

AlphaQ Advisors sold out of AbbVie (ABBV) in Q4 2023, closing a stake of 1,879 shares — an estimated $280K sold.

AlphaQ Advisors first reported a position in ABBV in Q4 2022 and held it in 4 quarters. The position peaked at $316K in Q4 2022. 3,322 funds tracked by Wall St. Rank hold ABBV as of Q4 2023.

  • AlphaQ Advisors reported no remaining AbbVie position as of Q4 2023 after selling out during the quarter.
  • AlphaQ Advisors sold 1,879 AbbVie shares in Q4 2023, an estimated $280K.
  • AlphaQ Advisors first reported a position in AbbVie in Q4 2022 and held it in 4 quarters.
  • AlphaQ Advisors's AbbVie position peaked at $316K in Q4 2022.
  • 3,322 funds tracked by Wall St. Rank held AbbVie as of Q4 2023.

Based on AlphaQ Advisors's 13F filing for Q4 2023, filed 29 Jan 2024.